Undeclared Desmethylcarbondenafil, a posphodiesterase (PDE-5) inhibitor, and dapoxetine, an ingredient not approved by the FDA, may present a health risk which could be life threatening.
L'Agenzia Europea dei
Medicinali (EMA) ha concluso una revisione completa di tutti i medicinali
prodotti da Roche, iniziata in seguito ad un'ispezione di farmacovigilanza di
routine all’inizio del 2012.
In the event a sterile product is compromised, patients are at risk for very serious infections.
Recent analysis of the product found that the products contained lead levels high as 167387 parts per million (ppm)
Some Medtronic models of its guidewires from recent lots have the potential for the coating on their surface to
delaminate and detach.
Undeclared Vardenafil and Tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to unsafe levels.
Clinical infections have also been reported to FDA, leading to some product recalls. The reported outcomes ranged from localized infections at injection sites to systemic infections that resulted in death.
Risk of aplastic anemia and allergic reactions.
No alarmism, but attention
Incretin mimetics or GPL-1 mimetics (glucagon like peptide-1) are molecules used for the treatment of type 2 diabetes mellitus. These drugs stimulate the GLP-1 receptors by acting as exogenous agonist (i.e. exenatide and liraglutide) or like inhibitors of the dipeptidyl peptidase-4 (DPP4), the enzyme responsible for the degradation of the endogenous hormone (i.e. sitagliptin and vildagliptin).1
80.211.154.110
